Skip to content

VERDE BIO HOLDINGS, INC.: 10-Q filed 2016-03-30

What VERDE BIO HOLDINGS, INC. reported in its quarterly report filed 2016-03-30 (fiscal Q3 2016): 14 published measures, 36 facts as tagged in accession 0001445866-16-001812.

This filing

Form
10-Q (quarterly report)
Filed
2016-03-30
Fiscal period
fiscal Q3 2016
Accession
0001445866-16-001812 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VERDE BIO HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-01-31200USD
At 2015-04-30126USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-01-311,181,725USD
At 2015-04-30586,807USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-01-31-1,181,525USD
At 2015-04-30-586,681USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-05-01 to 2015-01-31-54,667USD276

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-05-01 to 2016-01-31200USD276
2014-05-01 to 2015-01-3149,465USD276

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-01-31-2,380,139USD
At 2015-04-30-1,665,853USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-11-01 to 2016-01-31-115,741USD92
2015-05-01 to 2016-01-31-158,366USD276
2014-11-01 to 2015-01-31-92USD92
2014-05-01 to 2015-01-31-183,044USD276

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-11-01 to 2016-01-313,134USD92
2015-05-01 to 2016-01-319,593USD276
2014-11-01 to 2015-01-311,624USD92
2014-05-01 to 2015-01-3133,139USD276

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-11-01 to 2016-01-31115,741USD92
2015-05-01 to 2016-01-31158,366USD276
2014-11-01 to 2015-01-3192USD92
2014-05-01 to 2015-01-31183,302USD276

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-01-3132,498,502shares
At 2015-04-301,856,671shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-01-311,166,116USD
At 2015-04-301,077,315USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2015-11-01 to 2016-01-31-544,659USD92
2015-05-01 to 2016-01-31-714,286USD276
2014-11-01 to 2015-01-31-309,477USD92
2014-05-01 to 2015-01-31-684,500USD276

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-11-01 to 2016-01-311,650USD92
2015-05-01 to 2016-01-315,237USD276
2014-11-01 to 2015-01-31439USD92
2014-05-01 to 2015-01-3147,231USD276

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-05-01 to 2015-01-31342USD276

Inspect the source

Entity
VERDE BIO HOLDINGS, INC. / CIK 0001490054
Captured
2026-09-19T11:18:19.126Z
SEC response SHA-256
dd7cd08239c5c2462afbc7dbecad94ca6a89142a02ded38321628f853eea98c8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001490054.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))